Purpose

The purpose of the NASH Council is to shine a spotlight and coalesce an expanded set of stakeholders, in addition to hepatology, around the urgency of developing mechanisms for quantifying and addressing the silent epidemic of fatty liver disease (NAFLD) and non-alcoholic steteohepatitis (NASH) in the U.S. and abroad. Current estimates are that as many as 1 in 4 people already have NAFLD or NASH yet these conditions are underrecognized, underdiagnosed, and undertreated.

Read the 2017 meeting report


Workgroups

Public Education and Screening

To increase public understanding of NAFLD and NASH

Physician Education, Diagnosis, & Management

Improve physician education (pediatric and primary care – specialists) to increase the number of people diagnosed and connected to care

Patient Education and Support

Provide actionable information and support for diagnosed patients

Policy

Identify and support policies that facilitate the strategies and objectives of the other working groups


NASH News

Subscribe

Archive

* indicates required
Global Liver Institute

NASH Council Members

Want to be a member? Membership Application Form

Neal Barnard, MD, FACC, Physicians Committee for Responsible Medicine
Kathleen Corey, MD, MPH, Massachusetts General Hospital: Fatty Liver Disease Clinic
Dennis Cryer, MD, FAHA, CryerHealth, LLC
Lara Dimick-Santos, MD, Food & Drug Administration
Wayne Eskridge, Fatty Liver Foundation
Kathleen Greene, The Liver Forum
Brian Harvey, MD, PhD, Global Liver Institute
Scott Kahan, MD, MPH, National Center for Weight and Wellness/Obesity Society
Marko Korenjak, European Liver Patients Association
Michele Lentz, American Association of Clinical Endocrinologists
Veronica Miller, PhD, The Liver Forum
Cynthia Moylan, MD, American Heart Association
Shalewa Noel-Thomas, PhD, MPH, Cancer and Chronic Disease Prevention: DC Department of Health
Caitlin Ondracek, PhD, The Endocrine Society
Bennett Rosenthal, Key Antitodote
Arun Sanyal, MD, Virginia Commonwealth University School of Medicine
Rosemary Wickowski, COO, Fatty Liver Foundation

Observers

Jason Campagna, MD, PhD, Intercept
Chris Frates, Intercept
Heather Gartman, Gartman PR
Joseph Haas, The Pink Sheet
David Hartzman, Washington Talent
Brian Lee, PharmD, Bristol-Myers Squibb
Joel Lopez, JPA Health Communications
Shannon Richardson, Twist Marketing
Susan Stone, Allergan